[vc_wp_text el_class=”justify”]

WHO DO WE WORK WITH?

Our use case portfolio encompasses top 10 Pharma companies, research institutes, government organisations and medical device companies. We are currently working with global trials that are recruiting many thousands of patients from over 30 countries, on 6 continents. Clinpal supports virtually any language and the patient-facing content is always translated into the local languages. Studies using Clinpal involve more than 22,000 patients and more than 1600 study sites. Clinpal is also being used in smaller local trials in individual countries; this demonstrates the flexibility of the solution across many different use cases.

We have developed successful partnerships with our customers and this has led to repeated projects.

The table below summarizes some of the trials we are involved with.

SELECTED CLINPAL DEPLOYMENTS

CLIENT INDICATION PHASE DESCRIPTION COUNTRIES
TOP 10 PHARMA Diabetes IV Fully remote, online trial, using a SMART glucose meter integrated with Clinpal to capture blood glucose measurements in real time. 50 patients,1 study site. Study completed with excellent results. Click here to request more information FI
TOP 10 PHARMA Thrombosis N/A Bring Your Own Device (BYOD) eCOA validation study. Scientific work to develop a methodology and validate an ePRO patient questionnaire for use with patient’s own devices. Involving 25 patients in Spain and Finland. ES, FI
TOP 10 PHARMA Asthma III Site engagement portal with e-Learning, and site documents. Deployed to 140 sites, covering 10 e-Learning modules and an extensive document library with over 15 folders. RU, BG, ZA, NZ, UA, BR, AU, SK, GB, PL, RO, US, CA, GE
TOP 10 PHARMA Asthma III Moderate to severe asthma and other related indications. Clinpal is utilized across this important program as the patient recruitment and engagement solution as well as a site portal. Several studies, 2,000+ patients, 400+ sites in 8 countries. US, CA, MX, JP, AU, ZA, GB, UA
TOP 10 PHARMA & RESEARCH INSTITUTE Thrombosis IV 10,000 patient registry study, 500 sites, 28 countries. Clinpal is used as a comprehensive data capture solution, including eCRF’s, electronic patient questionnaires and site support features. GB, US, CZ, IT, RU, ZA, DE, CA, TH, NL, DK, TW, AU, KR, MY, HK, CN, AR, CH, TR, AE, BE, JP, MX, ES, EG, FR, BR
TOP 10 PHARMA & RESEARCH INSTITUTE Thrombosis IV 5,000 patient registry study, 700 sites, 18 countries. Clinpal is used as a comprehensive data capture solution, including eCRF’s, electronic patient questionnaires and site support features. GB, PL, NL, AU, RU, DK, DE, SA, IT, AE, FR, ES, EG, CA, SE, BR, NO, MX
TOP 10 PHARMA & GOVERNMENTAL RESEARCH SERVICES Diabetes IV 900 patient Diabetes registry. In a unique EHR/EMR integration study, Clinpal is used to recruit sites and patients based on a pre-qualification of candidates from an interface with national electronic medical records.
Clinpal is used for candidate assessment screening, randomization, letter production and patient (ePRO) questionnaires for direct eSource data capture and integrated Protocol and GCP eLearning. Clinpal utilizes CDISC standard for data interchange.		 GB
MEDICAL DEVICE COMPANY Glaucoma IV 500 patient registry study for a medical device company. Using Clinpal for site training and data capture. FR, BE, ES, DE, CH
BIOTECHNOLOGY COMPANY Obesity IV Innovative observatory study involving 300 patients in 4 countries. Clinpal is used for patient recruitment and engagement as well as data capture directly from patients using biometric devices, electronic patient reported outcomes (ePRO) and eCRFs. FR, US, IT, BE
BIOTECHNOLOGY Cystic Fibrosis Methodology A methodology study that incorporates several novel aspects of clinical trial conduct. Clinpal is used to support electronic informed consent, consolidation of audiometric tests, eSource data capture directly from patients, patient questionnaires, ePRO validation, and a patient-centric reward program that gamifies the clinical trial experience. US
MID SIZED PHARMA Obesity IV Design of a patient engagement platform to support a long term nutritional observational study. US
BIOTECHNOLOGY Oncology IV Observational study assessing inner health in 100 adult patients recruited in Australia who have received or are currently receiving anti-cancer medications. Clinpal is used for patient recruitment and engagement as well as data capture directly from patients using biometric devices, electronic patient reported outcomes (ePRO) and eCRFs. AU
DIGITAL THERAPEUTICS CNS / Depression II 100% remote randomized study with 120 participants and a single virtual site consisting of the investigator and a study therapist. The objective is to evaluate the efficacy of a digital therapy app for the treatment of depression and anxiety. FI
BIOTECHNOLOGY Cystic Fibrosis IV Scientific review and usability evaluation of a battery of eCOA / ePRO instruments in advance of deployment into a clinical trial. USA
RESEARCH INSTITUTE Oncology I Digital patient outreach and recruitment solution for a challenging oncology trial. ES, FR
CONSUMER PRODUCTS COMPANY Nutrition Validation Study Usability testing and validation of a new eCOA instrument that measures the efficacy of a functional food product for infants. GB
CLINICAL RESEARCH ORGANISATION (CRO) Women’s Health III Patient engagement and site engagement portals with eLearning, eConsent, ePRO and various patient engagement functionality. Deployed at 50 sites to 900 patients. US, CA
CALL CENTER PARTNER Ophthalmology HEOR Health economics and outcomes research project with 100 patients, supporting patient identification and enrollment. US, CA
TOP 10 PHARMA Autoimmune disorder Validation Study Non-interventional, multicenter, instrument validation study with 1,500 patients. GB
[/vc_wp_text]